Monday, August 10, 2020

Altimmune CEO on the biotech’s Covid-19 strategy, vaccine development

The Gaithersburg biotech is developing both an intranasal vaccine candidate for the virus and a treatment to prevent hospitalizations.



from https://www.bizjournals.com/baltimore/news/2020/08/10/altimmune-ceo-covid19-vaccine-strategy-development.html?ana=RSS&s=article_search
via https://baltimorecheckbook.tumblr.com/post/626065471873171456

No comments:

Post a Comment